Cesarean Delivery Recruiting Phase 4 Trials for Bupivacaine (DB00297)

IndicationStatusPhase
DBCOND0036001 (Cesarean Delivery)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03781388ED90 for Hyperbaric Bupivacaine in Super Obese ParturientsTreatment
NCT03039426Postoperative Cesarean Delivery Pain Relief; Diclofenac Versus BupivacainePrevention